15-keto-PGE2,
15-keto-prostaglandin E2,
15-ketoprostaglandin E2,
15-ketoprostaglandin E2, (11alpha)-isomer,
15-oxo-PGE2,
9,15-dioxo-11-hydroxyprosta-5,13-dienoic acid,
15-keto-prostaglandin E2,
15-Ketoprostaglandin E2,
15-Keto-PGE2,
15-Oxo-PGE2,
26441-05-4,
UNII-2S0F1FTK13,
2S0F1FTK13,
CHEBI:15547,
9,15-dioxo-11R-hydroxy-5Z,13E-prostadienoic acid,
(5Z,13E)-11alpha-Hydroxy-9,15-dioxoprost-13-enoate,
(5Z)-(15S)-11alpha-Hydroxy-9,15-dioxoprosta-13-enoate,
15-dehydro-prostaglandin E2,
Prosta-5,13-dien-1-oic acid, 11-hydroxy-9,15-dioxo-, (5Z,11alpha,13E)-,
9,15-Dioxo-11-hydroxyprosta-5,13-dienoic acid,
AC1NQXHH,
15-keto-PGE2-alpha,
15-KetoPGE2,
15-Oxo-PGE2-alpha,
15-Oxoprostaglandin E2,
15-keto Prostaglandin E2,
15-Dehydroprostaglandin E2,
9,15-Dioxo-11alpha-hydroxy-prosta-5Z,13E-dien-1-oic acid,
BML1-F11,
CHEMBL1447369,
SCHEMBL11681397,
YRTJDWROBKPZNV-KMXMBPPJSA-N,
HMS3648H19,
15-deoxy-15-oxo-prostaglandin E2,
1238AH,
LMFA03010030,
ZINC13540213,
SMP2_000019,
NCGC00161286-01,
C04707,
SR-01000946431,
SR-01000946431-1,
(5Z,13E)-11-alpha-hydroxy-9,15-dioxoprost-5,13-dienoate,
9,15-Dioxo-11.alpha.-hydroxyprosta-5Z,13E-dien-1-oic acid,
(5Z)-(13E)-11-alpha-hydroxy-9,15-dioxoprosta-5,13-dienoate,
(5Z)-(13E)-11-alpha-hydroxy-9,15-dioxoprosta-5,13-dienoic acid,
(5Z,13E)-11-alpha-hydroxy-9,15-dioxoprost-5,13-dienoic acid,
(5Z,13E)-11alpha-hydroxy-9,15-dioxoprosta-5,13-dienoic acid,
(Z)-7-[(1R,2R,3R)-3-hydroxy-5-oxo-2-[(E)-3-oxooct-1-enyl]cyclopentyl]hept-5-enoic acid,
Prosta-5,13-dien-1-oic acid, 11-hydroxy-9,15-dioxo-, (5Z,11.alpha.,13E)-,
FA(20:2(OH,Ke2,cyclo)),
C20H30O5,
C20-H30-O5,
CID5280719,
15-ketoprostaglandin E2, (11alpha)-isomer,
C026346,